vTv Therapeutics Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
vTv Therapeutics Inc. (VTVT) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $64.44 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-06
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $64.44M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $70.54M.
- 2025-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.40M.
- 2025-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $8.90M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2025-12-31 | $64.44M 10-K · filed 2026-03-10 |
| 2025-09-30 | $70.54M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.40M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $8.90M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $14.30M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $17.91M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $20.44M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $25.99M 10-Q · filed 2025-08-12 |
| 2023-12-31 | -$24.68M 10-K · filed 2026-03-10 |
| 2023-09-30 | -$25.23M 10-Q · filed 2024-11-12 |
| 2023-06-30 | -$25.28M 10-Q · filed 2024-11-12 |
| 2023-03-31 | -$19.19M 10-Q · filed 2024-08-08 |
| 2022-12-31 | -$10.74M 10-K · filed 2026-03-10 |
| 2021-12-31 | -$9.74M 10-K · filed 2025-03-20 |